As to how Anavex 2-73 compares to R/A/RC, I think the later is focused on beta amyloid reduction/prevention, as have all other attempts, of which, none have been successful. 2-73 is looking into "homeostatis" which is intended to provide cells with a mechanism that will clean out its own waste internally.
knuts, if you haven't listened to Dr. Missling's Bloomberg interview (posted yesterday by Penny Noodle), you should do so. Very positive.
Good luck to all RC shareholders.
News 
Market Data 
Discover 
